Skip to content

Clinical study for autologous fat extraction tissue in the treatment of erectile dysfunction

Clinical study for autologous fat extraction tissue in the treatment of erectile dysfunction

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019569
Enrollment
Unknown
Registered
2018-11-18
Start date
2018-12-03
Completion date
Unknown
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male erectile dysfunction

Interventions

Group 1:Single injection of autologous fat extracting tissue of the corpus cavernosum
Group 2:Take tadalafil 5mg once a night for 14 consecutive days

Sponsors

Urology & Andrology Renji Hospital, Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 70 years old, moderate and severe male penile erectile dysfunction, international erectile function score questionnaire - EF (IIEF-EF) score of 6-16 points; 2. Phosphodiesterase inhibitors are ineffective or ineffective; 3. The external genitalia develops normally, and there is no obvious abnormality in bilateral testicular, epididymis and spermatic cord palpation; 4. Willing to limit alcohol intake and stop taking drugs that affect sexual function (such as androgen replacement drugs, phosphodiesterase inhibitors and some proprietary Chinese medicines); 5. No life-threatening cardiovascular or endocrine diseases; 6. Volunteer to participate in the experiment and agree to follow-up.

Exclusion criteria

Exclusion criteria: 1. Other diseases in crisis other than erectile dysfunction, such as severe cardiovascular disease (such as angina pectoris, myocardial infarction, heart failure and arrhythmia), renal failure, respiratory failure, etc. 2. Androgen levels below 200 ng/dl; 3. After the researcher judges, has a history of obvious penile malformation, or has been treated with penile prosthesis implantation; 4. The patient's sexual partner plans to become pregnant during the study; 5. Currently participating, or have withdrawn from another clinical study that is incompatible with this study within the past 30 days; 6. Failure to adhere to hospital visits and follow-up, or other treatments during follow-up.

Design outcomes

Primary

MeasureTime frame
IIEF-EF;

Secondary

MeasureTime frame
EHS;NPT;Penile Doppler ultrasound;Penis length without erection;testosterone;PSA;

Countries

China

Contacts

Public ContactLu Mujun

Renji Hospital, Shanghai Jiaotong University School of Medicine

lumujun@163.com+86 18116267663

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026